Literature DB >> 6703680

In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole.

A M Freydière, Y Gille, S Tigaud, P Vincent.   

Abstract

The activities of niridazole and metronidazole were compared by an agar dilution method against 40 strains of Campylobacter fetus subsp. jejuni of human origin. Niridazole had a markedly higher activity than metronidazole.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6703680      PMCID： PMC185456          DOI： 10.1128/AAC.25.1.145

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

Review 2.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

Review 3.  The genus Campylobacter.

Authors:  R M Smibert
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

4.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

5.  Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.

Authors:  H Hof; V Sticht-Groh; K M Müller
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents.

Authors:  M Walder
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  Enrichment medium and control system for isolation of Campylobacter fetus subsp. jejuni from stools.

Authors:  F T Chan; A M Mackenzie
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948
  7 in total
  5 in total

1.  Susceptibility of Campylobacter species to niridazole.

Authors:  R M Bannatyne; M A Karmali; J Jackowski; M Roscoe
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

2.  Susceptibility of Campylobacter fetus subsp. jejuni to paromomycin.

Authors:  A M Freydiere; G Barbé; Y Gille; P Vincent
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

Review 3.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

4.  Antimicrobial effects of niridazole on Gardnerella vaginalis.

Authors:  R M Bannatyne; J Jackowski
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

5.  Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.

Authors:  H Hof; M Rieffert; V Sticht-Groh; O Zak; E H Schweizer
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.